GS-441524 is the main metabolite of remdesivir, an antiviral prodrug, and it has an average half-life of 24 hours in human patients. Its effectiveness has been demonstrated against the feline coronaviruses responsible for feline infectious peritonitis (FIP), a deadly systemic illness of cats.
Cats prone to FIP lack an immune deficiency or defect that would enable them to form antibodies and fend off the virus. As such, they are unable to resist its spread throughout the body and develop either wet or dry FIP.
It is recommended that treatment should last for 12 weeks.
The dosage according to the weight and symptoms of the patient is as follows:
The medicine should be stored at room temperature or at 2-4 degrees Celsius - this will be better to preserve its shelf life of one year. In addition, it is important to keep the medicine away from direct sunlight, because exposure to sunlight will reduce its efficacy.
You should not place in the medicine in a sub-zero environment because it can affect the concentration and therapeutic effect of the medicine, as the active ingredients can separate and form crystals.
